gvs 111 has been researched along with sulpiride in 1 studies
| Studies (gvs 111) | Trials (gvs 111) | Recent Studies (post-2010) (gvs 111) | Studies (sulpiride) | Trials (sulpiride) | Recent Studies (post-2010) (sulpiride) |
|---|---|---|---|---|---|
| 91 | 2 | 31 | 4,152 | 427 | 635 |
| Protein | Taxonomy | gvs 111 (IC50) | sulpiride (IC50) |
|---|---|---|---|
| Carbonic anhydrase 1 | Homo sapiens (human) | 1.2 | |
| Carbonic anhydrase 2 | Homo sapiens (human) | 0.04 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 2.019 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.0858 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.2651 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.2215 | |
| Carbonic anhydrase 4 | Bos taurus (cattle) | 0.62 | |
| D(2) dopamine receptor | Canis lupus familiaris (dog) | 0.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gudasheva, TA | 1 |
1 other study(ies) available for gvs 111 and sulpiride
| Article | Year |
|---|---|
[Strategy for the development of dipeptide drugs].
Topics: Biological Availability; Biopharmaceutics; Blood-Brain Barrier; Dipeptides; Drug Design; Humans; Nootropic Agents; Piracetam; Proline; Protein Conformation; Psychotropic Drugs; Receptors, Cell Surface; Sulpiride; Tyrosine | 2011 |